The importance of a higher dose of a mineralocorticoid receptor antagonist in reducing risk of reccurent hospitalization in a patient with advanced chronic heart failure - A case report

Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney disease

European Journal of Heart Failure ◽

10.1002/ejhf.218 ◽

2015 ◽

Vol 17 (2) ◽

pp. 224-232 ◽

Cited By ~ 54

Author(s):

Bertram Pitt ◽

Stefan D. Anker ◽

Michael Böhm ◽

Mihai Gheorghiade ◽

Lars Køber ◽

...

Keyword(s):

Heart Failure ◽

Chronic Kidney Disease ◽

Chronic Heart Failure ◽

Kidney Disease ◽

Receptor Antagonist ◽

Randomized Study ◽

Effects of mineralocorticoid receptor antagonist spironolactone on cardiac sympathetic nerve activity and prognosis in patients with chronic heart failure

International Journal of Cardiology ◽

10.1016/j.ijcard.2011.12.080 ◽

2013 ◽

Vol 167 (1) ◽

pp. 244-249 ◽

Cited By ~ 15

Author(s):

Shu Kasama ◽

Takuji Toyama ◽

Hiroyuki Sumino ◽

Hisao Kumakura ◽

Yoshiaki Takayama ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Receptor Antagonist ◽

Sympathetic Nerve ◽

Sympathetic Nerve Activity ◽

Cardiac Sympathetic Nerve ◽

Nerve Activity ◽

Cardiac Sympathetic Nerve Activity

ELEVATED GALECTIN-3 DOES NOT PREDICT BENEFIT FROM MINERALOCORTICOID RECEPTOR ANTAGONIST USE IN PATIENTS WITH CHRONIC HEART FAILURE DUE TO LEFT VENTRICULAR SYSTOLIC DYSFUNCTION

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(15)60970-6 ◽

2015 ◽

Vol 65 (10) ◽

pp. A970

Author(s):

Parul U. Gandhi ◽

Shweta Motiwala ◽

Arianna Belcher ◽

Hanna Gaggin ◽

Rory Weiner ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Receptor Antagonist ◽

Left Ventricular Systolic Dysfunction ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Ventricular Systolic Dysfunction ◽

Galectin 3

Faculty Opinions recommendation of Rationale and design of MinerAlocorticoid Receptor antagonist Tolerability Study-Heart Failure (ARTS-HF): a randomized study of finerenone vs. eplerenone in patients who have worsening chronic heart failure with diabetes and/or chronic kidney disease.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725355266.793521191 ◽

2016 ◽

Author(s):

Jai Radhakrishnan

Keyword(s):

Heart Failure ◽

Chronic Kidney Disease ◽

Chronic Heart Failure ◽

Kidney Disease ◽

Receptor Antagonist ◽

Randomized Study ◽

Galectin-3 and mineralocorticoid receptor antagonist use in patients with chronic heart failure due to left ventricular systolic dysfunction

American Heart Journal ◽

10.1016/j.ahj.2014.12.012 ◽

2015 ◽

Vol 169 (3) ◽

pp. 404-411.e3 ◽

Cited By ~ 22

Author(s):

Parul U. Gandhi ◽

Shweta R. Motiwala ◽

Arianna M. Belcher ◽

Hanna K. Gaggin ◽

Rory B. Weiner ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Receptor Antagonist ◽

Left Ventricular Systolic Dysfunction ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Ventricular Systolic Dysfunction ◽

Galectin 3

O116 Does aspirin interfere with the clinical benefits of the mineralocorticoid receptor antagonist eplerenone in systolic chronic heart failure?: Analysis of the EMPHASIS-HF study

Global Heart ◽

10.1016/j.gheart.2014.03.1327 ◽

2014 ◽

Vol 9 (1) ◽

pp. e31

Author(s):

Henry Krum ◽

Bertram Pitt ◽

John McMurray ◽

Karl Swedberg ◽

Dirk van Veldhuisen ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Failure Analysis ◽

Receptor Antagonist ◽

Clinical Benefits

The use of a novel non-steroidal mineralocorticoid receptor antagonist finerenone for the treatment of chronic heart failure

Medicine ◽

10.1097/md.0000000000010254 ◽

2018 ◽

Vol 97 (16) ◽

pp. e0254 ◽

Cited By ~ 19

Author(s):

Hui Pei ◽

Wei Wang ◽

Di Zhao ◽

Lei Wang ◽

Guo-Hai Su ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Receptor Antagonist ◽

Interaction Between Mineralocorticoid Receptor Antagonist and Soluble ST2 in Heart Failure with Preserved Ejection Fraction

Journal of Cardiac Failure ◽

10.1016/j.cardfail.2017.08.062 ◽

2017 ◽

Vol 23 (10) ◽

pp. S20

Author(s):

Akinori Sugano ◽

Yoshihiro Seo ◽

Tomoko Ishizu ◽

Masayoshi Yamamoto ◽

Yoshie Hamada ◽

...

Keyword(s):

Heart Failure ◽

Ejection Fraction ◽

Receptor Antagonist ◽

Preserved Ejection Fraction ◽

Soluble St2

Characterization of Mineralocorticoid Receptor Antagonist Therapy Initiation in High-Risk Patients With Heart Failure

Circulation Cardiovascular Quality and Outcomes ◽

10.1161/circoutcomes.116.002946 ◽

2017 ◽

Vol 10 (1) ◽

Cited By ~ 12

Author(s):

Lauren B. Cooper ◽

Bradley G. Hammill ◽

Eric D. Peterson ◽

Bertram Pitt ◽

Matthew L. Maciejewski ◽

...

Keyword(s):

Heart Failure ◽

High Risk ◽

Receptor Antagonist ◽

Antagonist Therapy ◽

Therapy Initiation ◽

Patients With Heart Failure ◽

Risk Patients

Epithelial Sodium Channel Genotype Is Associated with Elevated Potassium among Patients with Heart Failure Taking a Mineralocorticoid Receptor Antagonist

Journal of Cardiac Failure ◽

10.1016/j.cardfail.2013.06.185 ◽

2013 ◽

Vol 19 (8) ◽

pp. S56

Author(s):

Alexandra Goncharenko ◽

Andrew Kadlec ◽

Adam Bress ◽

Shitalben Patel ◽

Orly Vardeny ◽

...

Keyword(s):

Heart Failure ◽

Sodium Channel ◽

Receptor Antagonist ◽

Epithelial Sodium Channel ◽

Patients With Heart Failure